Baycrest appoints Dr. Randy McIntosh as Vice-President of Research and Director of the world-renowned Rotman Research Institute

Toronto, Ontario, May 12, 2010 — Baycrest has appointed one of Canada’s leading cognitive scientists as the new Vice-President of Research and Director of its world-renowned Rotman Research Institute (RRI).

Dr. Randy McIntosh, 45, is currently leading a multi-million dollar project which has the RRI partnered with an international team of scientists to construct the world’s first virtual functioning brain. The massive project – akin to decoding the human genome – has the potential to revolutionize how clinicians assess and treat various brain disorders, including cognitive impairment caused by stroke and Alzheimer’s disease.

“Dr. McIntosh’s expertise in functional brain mapping, and his skills in building international partnerships and taking our science program in new directions, will ensure Baycrest continues to be a world leader in cognitive neuroscience research and soon a formidable presence in the rapidly growing industry of brain fitness products,” said President and CEO Dr. William Reichman.

A world-renowned expert in the use of neuro-imaging methods (fMRI, PET, EEG and MEG) and computational modeling to understand how brain networks change with aging and how the brain recovers from damage or disease, The Globe and Mail has ranked Dr. McIntosh among the top scientists in Canada’s largest city poised to break new ground in their field of research.

He takes over the reigns at a time when neuroscience is pushing into exciting new areas such as population neuroscience – the study of how genes and environment shape brain health from infancy to old age. Last year as Director of the RRI, Dr. McIntosh recruited a pioneer in this emerging field from the U.K., Dr. Tomas Paus, to oversee the creation of the Toronto Trans-generational Brain and Body Centre, a joint initiative between Baycrest and Sick Kids.

“It’s a tremendous time to be part of Baycrest,” said Dr. McIntosh, who will oversee a staff of over 150 scientists, post-docs, research assistants and grad students in the RRI and its applied wing, the Kunin-Lunenfeld Applied Research Unit. “There is a new level of excitement for the research that we do here and I am confident that with the team we have, we are in a great position to deliver novel understanding about aging and the brain, and innovative approaches to ensure brain health across the lifespan.”

His ascension to the top research job at Baycrest comes at a time when the centre is about to stake a claim in the booming brain fitness market. With a $10 million investment from the Ontario government, matching another $10 million in private donations, Baycrest and Canada’s innovation incubator MaRS have teamed up to create Cogniciti, a for-profit company that will produce scientifically-proven brain fitness products for aging boomers.

Dr. McIntosh joined the RRI in 1994 and served as Interim Vice-President of Research at Baycrest in 2009 when Dr. Donald Stuss retired. Dr. Stuss is a world-renowned frontal lobes expert and founding director of the RRI. In its 21-year history under his stewardship, the RRI has built a stellar reputation in aging brain science and the ability to attract some of the world’s most eminent brain researchers to Toronto.

Dr. McIntosh received his BSc and MSc in Psychology from the University of Calgary and his PhD in Psychology (Behavioural Neuroscience) from the University of Texas. He is a member of the Society for Neuroscience, Cognitive Neuroscience Society and the Organization for Human Brain Mapping, and a professor in the Department of Psychology at the University of Toronto.

Baycrest is an academic health sciences centre, internationally renowned for its care of aging adults and its excellence in aging brain research, clinical interventions and treatments, and promising cognitive rehabilitation strategies.

– 30 –

For more information on this release, please contact

Kelly Connelly
Senior Media Officer
Baycrest
416-785-2432
kconnelly@baycrest.org